Welcome to LookChem.com Sign In|Join Free
  • or
Ethyl 5,6,7,8-tetrahydro-1-indolizinecarboxylate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

61009-77-6

Post Buying Request

61009-77-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

61009-77-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 61009-77-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,0,0 and 9 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 61009-77:
(7*6)+(6*1)+(5*0)+(4*0)+(3*9)+(2*7)+(1*7)=96
96 % 10 = 6
So 61009-77-6 is a valid CAS Registry Number.

61009-77-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 5,6,7,8-tetrahydroindolizine-1-carboxylate

1.2 Other means of identification

Product number -
Other names 1-Indolizinecarboxylic acid,5,6,7,8-tetrahydro-,ethyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:61009-77-6 SDS

61009-77-6Relevant academic research and scientific papers

HEPATITIS B CAPSID ASSEMBLY MODULATORS

-

Paragraph 0376; 0378, (2019/12/30)

Described herein are hepatitis B capsid assembly modulators and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of hepatitis B.

FUSED PYRROLEDICARBOXAMIDES AND THEIR USE AS PHARMACEUTICALS

-

Page/Page column 111; 113, (2013/08/15)

The present invention relates to fused pyrroledicarboxamides of the formula (I), in which R1 to R9, X, m and n are as defined in the claims. The compounds of the formula (I) are inhibitors of the acid-sensitive potassium channel TASK-1 and suitable for the treatment of TASK-1 channel-mediated diseases such as arrhythmias, in particular atrial arrhythmias like atrial fibrillation or atrial flutter, and respiratory disorders, in particular sleep-related respiratory disorders like sleep apnea, for example.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 61009-77-6